اینستاگرام تی پی بین
همایش ، رویداد ، ژورنال
حوزه های تحت پوشش رویداد
  • overcoming inherent limits to pharmaceutical manufacturing quality performance with qbd (quality by design)

    جزئیات بیشتر مقاله
    • تاریخ ارائه: 1392/07/24
    • تاریخ انتشار در تی پی بین: 1392/07/24
    • تعداد بازدید: 893
    • تعداد پرسش و پاسخ ها: 0
    • شماره تماس دبیرخانه رویداد: -
     pharmaceutical development and manufacturing systems typically rely on a quality by testing (qbt) model that use release testing and other measures to ensure product quality. however, there is a significant gap between typical pharmaceutical production system capability and supplied quality. to sustain high levels of product supply quality, the industry incurs a high cost of quality and retains value at risk. this paper presents research results from a systems engineering perspective using case study data that quantitatively evaluates the gap between pharmaceutical production system sigma and supplied quality. it also identifies the extent to which emerging quality by design (qbd) eliminates system contradictions that prohibit higher production system sigma performance.

سوال خود را در مورد این مقاله مطرح نمایید :

با انتخاب دکمه ثبت پرسش، موافقت خود را با قوانین انتشار محتوا در وبسایت تی پی بین اعلام می کنم